SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Harmon who wrote (1352)8/11/1998 12:33:00 PM
From: Rudy Saucillo  Read Replies (3) of 2742
 
Galton/Boardmembers/Shareholders:

Here's Techne's 4Q and annual results which should serve as an example to Cistron management. In fact, if Cistron management performed like Techne's, we wouldn't be waffling at substantially below book.

biz.yahoo.com

Cistron management take note: Techne reports 37% - 40% *increases* in net income for the quarter and year due primarily to *increased sales*. Their report is exemplary.

Historically, Techne has communicated very well with their shareholders and aggressively defined plans to increase shareholder value. When acquisitions couldn't be found, they told shareholders they were implementing a stock buyback plan to continue delivering shareholder value. Sales have consistently grown. And as we know, Techne recently acquired Genzyme's Research Products Division. This is a growing, thriving business.

Contrast CIST's performance with Techne's...Cistron's business plan - focused on the periodontal diagnostic - is long out of date and no revision has been provided to shareholders. We don't know if the company is for sale or if Cistron is looking for acquisitions. We *do* know the reagents business is floundering...flat or decreasing sales since the IMNX settlement.

Galton...tell shareholders how you intend to provide shareholder value...and then go off and make things happen.

Shareholders...there's no excuse for Cistron's pathetic performance. If we don't receive some satisfaction from Cistron management very soon, I believe it's time to organize and plan for changes at the annual meeting.

Rudy
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext